Name | WAY-328158 |
---|---|
Synonyms | 3-Isoxazolecarboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-5-(4-fluorophenyl)- |
Description | BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C19H16FN3O3S |
---|---|
Molecular Weight | 385.41 |